The Readout Loud

324 Episodes

1. Episode 183: Greg Zuckerman on the vaccine race, plus Biogen's troubled launch

   Published: 21/10/2021
2. Episode 182: The FDA star search, more booster debates, & the future of mRNA

   Published: 14/10/2021
3. Episode 181: Brent Hodge on filming Shkreli, the next NIH director, and a looming FDA deadline

   Published: 07/10/2021
4. Episode 180: Health equity 'tourism,' an $11B biopharma acquisition, & a bony Covid protest

   Published: 30/09/2021
5. Episode 179: Scott Gottlieb on the next pandemic, another Covid winter, & Aduhelm's slow rollout

   Published: 23/09/2021
6. Episode 178: Futuristic prosthetics, a treatment for ALS, & intrigue at the Holmes trial

   Published: 16/09/2021
7. Episode 177: Bijan Salehizadeh on Covid tests, plus Verily's moment of truth

   Published: 09/09/2021
8. Episode 176: Elizabeth Holmes on trial, FDA in disarray, & the quest for Covid antivirals

   Published: 02/09/2021
9. Episode 175: Dorit Reiss on vaccine mandates, plus biotech's messy summer

   Published: 26/08/2021
10. Episode 174: Biotech's trust issues, overwhelmed health workers, & the nuances of insider trading

    Published: 19/08/2021
11. Episode 173: Biden's drug pricing plan, Wall Street's Alzheimer's fixation, & daily 5 a.m. alarms

    Published: 12/08/2021
12. Episode 172: The mRNA gold rush, Delta's alarming rise, & the next treatment for Alzheimer's

    Published: 05/08/2021
13. Episode 171: The quest for a Covid pill, a microbiome gut-check, & CRISPR on the big screen

    Published: 29/07/2021
14. Episode 170: Céline Gounder on breakthrough infections, plus the power of lobbying

    Published: 22/07/2021
15. Episode 169: Dan Diamond on covering Biden, plus the FDA's future, & the latest Aduhelm twist

    Published: 15/07/2021
16. Episode 168: Aduhelm's latest twist, & how Covid variants are shaping the summer

    Published: 08/07/2021
17. Episode 167: George Yancopoulos on biotech in 2021, plus a CRISPR milestone, Biogen's FDA saga,

    Published: 01/07/2021
18. Episode 166: FDA inner workings, GSK's foggy future, & the alarming rise in colorectal cancer

    Published: 24/06/2021
19. Episode 165: Paul Offit on the Covid vaccine booster debate, & Robyn Karnauskas' call of the decade

    Published: 17/06/2021
20. Episode 164: Every angle on the FDA's polarizing approval of Biogen's Alzheimer's drug

    Published: 10/06/2021